A RESUSCITATION STRATEGY BASED ON THE OPTIMIZATION OF STROKE VOLUME IS ASSOCIATED WITH
SIGNIFICANT CLINICAL AND ECONOMIC OUTCOMES
Results from a recent study at the University of Kansas Medical Center highlight the benefits of fluid management guided by Cheetah Medical technology.
A resuscitation strategy guided by optimization of stroke volume in patients with severe sepsis and septic shock, is associated with:
- Reduced length of stay (LOS)
- Reduced fluid balance
- Reduced time on vasopressors
- Decreased need for mechanical ventilation
Volume Fluid Therapy
|Usual Care |
|Fluid Balance (Liters)||1.77L ± 0.60||5.36L ± 1.01||3.59L1,2
|ICU LOS (Days)||5.98 ± 0.68||8.87 ± 1.18||2.89 days
|Pressor Use (Hours)||32.08 ± 5.22||64.86 ± 8.39||32.78 hours
|Mechanical Ventilation (Relative Risk)||.51||CI 0.36 - .072
THESE CLINICAL OUTCOMES MAY DRIVE SIGNIFICANT ECONOMIC BENEFITS
Volume Fluid Therapy
|Usual Care |
|Δ/p Value||Cost Assumptions||Cost Avoidance|
|ESTIMATED SAVINGS PER TREATED PATIENT||$10,894|
|Fluid Balance (Liters)||1.77L ± 0.60||5.36L ± 1.01||3.59L12 |
|ICU LOS (Days)||5.98 ± 0.68||8.87 ± 1.18||2.89 days |
|$US 4,001/ICU day3|
$US 906/floor day4
|Pressor Use (Hours)||32.08 ± 5.22||64.86 ± 8.39||32.78 hours |
|Mechanical Ventilation (Relative Risk)||.51||CI 0.36 - .072|
ICU Length of Stay (LOS): 2.89 days x ($4004 [Avg ICU Day] – $906 [Avg Floor Day]) = $8953.
Mechanical Ventilation (MV): $1522 x 5.1 days x .25 = $19404,5
1. Incremental cost of MV $1522/day
2. Average duration of MV in septic shock 5.1 days.
3. Assumes an absolute 25% reduction of patients receiving mechanical ventilation.
1. Stroke volume guided resuscitation in severe sepsis and septic shock decreases time on pressors and ICU stay. H Latham; CD Bengtson; L Satterwhite; M Stites; SQ Simpson. University of Kansas Medical Center, Kansas City, United States. ISICEM, March 2017. 2. Stroke volume guided resuscitation in severe sepsis and septic shock decreases need for mechanical ventilation. H Latham; CD Bengtson; L Satterwhite; M Stites; SQ Simpson. University of Kansas Medical Center, Kansas City, United States. ISICEM, March 2017. 3. Huynh T, et al. The frequency and cost of treatment perceived to be futile in critical care. JAMA Internal Med 2013; 173: 1887-1894. 4. Premier Data Set, 2013. Premier, Inc. 5. Dasta, Joseph F. MSc, FCCM; McLaughlin, Trent P. PhD; Mody, Samir H. PharmD, MBA; Piech, Catherine Tak MBA. Daily cost of an intensive care unit day: The contributionof mechanical ventilation. Critical Care Medicine, June 2005: Volume 33(6):1266-127.
Cheetah Medical Economic Analysis Tool
The Economic Analysis Tool was created by Adi Renbaum of ANR Consulting and Thomas Hopkins, MD MBA (Duke University) to demonstrate a new approach to business intelligence in healthcare, providing clinicians and executives with the tools they need to simultaneously improve patient care and avoid costs. The Economic Analysis Tool can be used as part of a personalized and predictive model that can be leveraged to evaluate the cost effectiveness of purchasing noninvasive hemodynamic monitoring equipment.
The Economic Analysis Tool is product-neutral, and being such, does not take into consideration product cost.
For a more detailed analysis of how the 100% noninvasive CHEETAH NICOM and Starling SV hemodynamic systems can address your particular needs, please click on the button at the bottom of this page, and a local representative will contact you.
Cost Avoidance With Use of Advanced Hemodynamic Monitoring
The Budget Impact Analysis presented here is a simplified pro forma representation of the potential economic impact of improved fluid management. This model is based on the existing medical literature on Goal Directed Therapy and is not meant to predict actual results.
Copyright Cheetah Medical Inc. All Rights Reserved.